The PE Ratio as of July 2024 (TTM) for Amryt Pharma plc (AMYT) is 39.73

According to Amryt Pharma plc’s latest financial reports and current stock price. The company's current PE Ratio is 39.73. This represents a change of -848.40% compared to the average of -5.31 of the last 4 quarters.

Amryt Pharma plc (AMYT) Historical PE Ratio (quarterly & annually)

How has AMYT PE Ratio performed in the past?

The mean historical PE Ratio of Amryt Pharma plc over the last ten years is -15.92. The current 39.73 PE Ratio has changed -25056.29% with respect to the historical average. Over the past ten years (40 quarters), AMYT's PE Ratio was at its highest in in the December 2021 quarter at 7.70. The PE Ratio was at its lowest in in the June 2021 quarter at -16.00.

Amryt Pharma plc (AMYT) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Amryt Pharma plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Amryt Pharma plc (AMYT) Average PE Ratio

How has AMYT PE Ratio performed in the past?

The current PE Ratio of Amryt Pharma plc (AMYT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Amryt Pharma plc (AMYT) PE Ratio vs. Peers

How is AMYT’s PE Ratio compared to its peers?

Amryt Pharma plc’s PE Ratio is greater than Universe Pharmaceuticals INC (-2.20), greater than Regencell Bioscience Holdings Limited (-33.94), greater than Indigenous Bloom Hemp Corp. (-0.06), greater than Eagle Pharmaceuticals, Inc. (6.86), greater than Sangui Biotech International, Inc. (-7.32), greater than Qilian International Holding Group Limited (-28.26), greater than IM Cannabis Corp. (-2.48), less than GelStat Corporation (0), greater than Pacira BioSciences, Inc. (-2.64), greater than Collegium Pharmaceutical, Inc. (13.22), greater than Prestige Consumer Healthcare Inc. (12.50), greater than Incannex Healthcare Limited (16.83), greater than Phibro Animal Health Corporation (-1.74), less than Shuttle Pharmaceuticals Holdings, Inc. (58.03), greater than Mallinckrodt plc (-0.99), greater than Organogenesis Holdings Inc. (-0.00), greater than Lucy Scientific Discovery Inc. (28.96), greater than Alimera Sciences, Inc. (-0.72), greater than null (-14.14),

Build a custom stock screener for Amryt Pharma plc (AMYT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Amryt Pharma plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Amryt Pharma plc (AMYT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Amryt Pharma plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.